SOCS3 and cancer: Overall, 66 cancer tissues (91.7%) and 48 pericarcinoma tissues (66.7%) expressed SOCS-3 mRNA (RI, 0.373±0.284 and 0.376±0.247, respectively; t=0.067, P=0.947).